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Background & objectives: This study was designed to estimate HIV seroprevalence among
tuberculosis patients presenting to tertiary care centre in Delhi.
Methods: Cross-sectional prevalence study among all patients presenting to the inpatient and
outpatient departments of All India Institute of Medical Sciences (AIIMS), New Delhi, and receiving
anti-tuberculosis treatment from May 2003 to April 2005.
Results: Of the 448 patients who presented to the TB clinic during the study period, 23 (5.1%)
were previously tested HIV-positive. An additional 21 patients (4.6%) refused testing, and 30 (6.7%)
were lost to follow up. Of the remaining 374 patients who consented to testing, 31 (8.3%) were
found to be HIV-positive. Risk factors for HIV seropositivity included high-risk sexual behaviours
(48% in HIV-TB co-infected vs. 6% in TB infected patients, P<0.001) and history of blood
transfusion (23% vs. 5%; P=0.002).
Interpretation & conclusion: Previous studies from the same hospital published in 2000 and 2003
reported HIV seroprevalence among TB patients to be 0.4 and 9.4 per cent respectively. The current
study documents a persistently high seropositivity among TB patients. These results emphasize the
acute need for improved detection and treatment for HIV among TB patients in northern India.
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Tuberculosis (TB) and HIV epidemics are
heavily intertwined, each increasing the morbidity
and mortality of the other.  In India, there are over
three million annual prevalent active TB cases and
over five million HIV-positive individuals. Although
the country-wide prevalence remains less than 1 per
cent (0.91%),1 a vast majority of HIV-positive
patients do not know their status; less than 5 per cent
of the approximately 770,000 patients in need of
antiretroviral therapy currently have access to it2.
Strategies to detect and treat HIV are thus of a
pressing concern. Given that TB is the most common
opportunistic infection in HIV infected individuals
in India3,4,  detecting HIV among TB patients
presenting to the health sector represents an
important public health opportunity. Programmatic
planning requires the availability of up-to-date data
on HIV seroprevalence among different populations
of TB patients.
Data from several sources suggest a high burden
of HIV among TB patients in India.  Overall, WHO
has reported an HIV seroprevalence of 5.2 per cent
among adult TB patients in India for the year 20025.
Other data suggest that these rates are not only high,
but increasing. For example, in Pune, Maharastra,
HIV seroprevalence among TB patients increased
from 10 per cent in 1995 to 28.75 per cent in 20006.
A similar survey done at Pennathur sanatorium,
Tamil Nadu, had documented a rise from 2 per cent
in 1992-93 to 9.4 per cent in 1997-987. This trend
has been observed in rural pockets of Thanjavur,
Tamil Nadu as well8. Recently published sentinel
surveillance report by National AIDS Control
Organization (NACO) shows an alarming HIV
seroprevalence of 9.0 per cent amongst TB patients
form four districts, each one in high prevalence
State1.
Data from northern India are sparse. Apart
from Delhi, parallel sentinel surveillance data are
not  avai lable  for  States  with low HIV
seroprevalence9. Previous work at our institution
has shown a dramatic  increase in HIV
seroprevalence (from 0.4 to 9.4%) among patients
with TB presenting to the outpatient medicine
department and inpatient wards of the All India
Institute of Medical Sciences (AIIMS) hospital in
New Delhi from 1994-1995 to 2000-200210,11.
Recently, data published from Agra, Uttar Pradesh,
showed HIV seroprevalence of 4.3 per cent
amongst TB patients12. Given such an alarming rise
in seroprevalence rates, this study was planned to
continue to monitor HIV seroprevalence among TB
patients followed at the outpatient department or
admitted to the wards of the AIIMS hospital from
May 2003 to April 2005.
Material & Methods
We performed a cross-sectional study of HIV
seroprevalence among 448 consecutive TB patients
>3 yr of age being started on anti-tuberculosis
treatment (ATT) at AIIMS, New Delhi during May
2003 and April 2005. Some of these patients might
have received treatment from outside clinics or
hospitals prior to coming to AIIMS; thus both new
and retreatment cases were included. Owing to the
complexity of TB diagnosis and the aims of the study
to assess those patients interacting with the health
system for the purposes of treatment, no other
diagnostic criteria were specified. The patients were
counselled before and after being tested for HIV. For
those patients who tested positive for HIV, further
work-up and management were done (data not
shown). Written informed consent was obtained from
all patients. The study received approval from the
ethical review committee of AIIMS.
HIV serology: Peripheral venous blood samples were
tested for the presence of antibodies against HIV-1
and -2 by two different enzyme immunoassays (HI-
Chex, Xcyton Diagnostics, Bangalore, India and
Biotest anti HIV tetra ELISA, Biotest AG, Germany).
Samples testing positive on both immunoassays were
recorded as HIV-positive. Discordant results were
repeated, which subsequently resolved any prior
inconsistencies.
Statistical analysis: Data were analyzed using the
SPSS 10.0 statistical package (SPSS Inc., USA).
Results
Four hundred forty eight patients with TB attending
the outpatient medical clinic and inpatient wards at the
AIIMS hospital were screened for inclusion in the study.
Twenty three TB (5.1%) patients were known HIV-
positive and were excluded from the study. Twenty one
patients (4.6%) refused testing. The main reasons for
refusal were perceived absence of risk factors or
apprehensiveness in front of family members. Thirty
patients (6.7%) were lost to follow up after the screening
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interview. HIV test was done in 374 TB patients who
consented; out of these, 31 (8.3%) were found to be
HIV-positive. This figure was chosen as the best
estimate of HIV seroprevalence in our population
(8.3%, 95% CI: 5.4 to 11.21).
Of the 374 patients, 224 (59.9 %) were residents
of Delhi, and the remaining were from the
neighboring States such as Uttar Pradesh, Haryana,
and Bihar. Possible risk factors for HIV were
promiscuity (48% in HIV-TB co-infected vs. 6% in
only TB patients; P<0.001) and history of blood
transfusion (23% in HIV-TB co-infected vs. 5% in
only TB patients; P=0.002). Statistically significant
difference was observed in the proportion of truck
drivers (32 vs. 4%; P<0.001) and farmers (19 vs. 7%;
P=0.003) present in HIV-TB co-infected and only
TB patients.
Fig. provides approximate 95 per cent confidence
limits for point estimates of prevalence from each of
the studies from AIIMS; the current estimate and that
from 2000-2002 estimates did not reach statistical
significance.
Discussion
This study demonstrated that the HIV
seroprevalence among TB patients presenting to the
outpatient medical clinic or the inpatient wards of
the AIIMS hospital from 2003-2005 was 8.3 per cent,
as compared to previous reports of 0.4 per cent in
1995-9910 and 9.4 per cent in 2000-200211 in the same
settings. These data suggest that the rate of HIV
positivity continues to be high and possibly
increasing among TB cases at AIIMS. The
persistently high HIV seroprevalence in this patient
population is of concern both in terms of patient
management and public health perspective. Similar
study from northern India reported HIV
seroprevalence of 4.3 per cent among TB patients12.
Low prevalence (0.4%) during 1995-1999 was
probably due to infancy of the potential devastating
HIV epidemic and also because it initially started
from the southern part of India. Higher rates of 9.4
and 8.3 per cent observed over the subsequent years
represent the rapidity with which the epidemic has
spread in the whole of country. The trend observed
over the years highlights the importance of
continuous surveillance and in-time appropriate
preventive measures.
There are several potential limitations of this
study. A strong bias in the study population as it is
from a tertiary care referral centre and that this
particular population could have had a greater
prevalence of HIV than among TB patients generally
in northern India.  Additionally, the patients in the
study were selected on the basis of receiving ATT from
treating clinicians at AIIMS, a criterion which may
only partially reflect underlying TB disease. The
reason for selecting these patients as such was to
provide estimates among patients interacting with the
health system for the purposes of ATT, which is
probably the most important patient population from
a public health programming perspective. The
generalizability of the results is lessened by variability
in diagnostics and treatment practices at different
clinics in India. In the absence of a simple test for the
diagnosis of active TB, keeping in view the varied
clinical presentation, this approach is reasonable.
Despite these limitations, the high HIV seroprevalence
in this population is a cause for alarm and a call to
action in combating these twin epidemics.
Knowledge of HIV status in a TB patient is critical
from both patient and public health perspectives. In
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Fig. HIV seroprevalence (with 95% confidence interval) among
TB patients at AIIMS (1995-2005).
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those patients who test seropositive for HIV, better
care can be provided in the form of effective combined
ATT and antiretroviral treatment. If an HIV-positive
TB patient on ATT worsens or fails to improve with
therapy, the possibility of other co-existing
opportunistic infections or imune reconstitution
syndome should be considered. Knowledge of a
person's HIV serostatus also provides the opportunity
to administer prophylaxis for opportunistic infections
and thereby reduces morbidity and mortality. The
spouse and relatives of HIV seropositve patients may
also be counselled on HIV infection and its modes of
transmission and prognosis, preventing the spread of
infection. Spouses may be educated on safe sex
practices and may be offered testing themselves.
Currently, the recommendation from WHO is for
continued surveillance in low prevalence areas with
HIV infection among TB patients13. It is likely that
voluntary counselling and testing (VCT) alone may
not be sufficient in increasing HIV testing among TB
patients in India, and a routine approach is necessary.
Data from modeling from USA have suggested that a
HIV seroprevalence even on the order of 1 per cent
among TB patients would indicate that routine HIV
screening among these patients is cost-effective14.
In conclusion, there is a pressing need for the
Revised National Tuberculosis Control Programme
(RNTCP) and NACO to collaborate on feasibility
of making HIV counselling and testing routinely
available to all DOTS and other TB patients
throughout India.
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